MedTrace Logo

Low-dose Combination of Three Antihypertensive Drugs

NCT02710552 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-03-17

No results posted yet for this study

Summary

The aim of the study is to compare the efficacy and safety of low-dose combination of three antihypertensive drugs versus fixed high-dose combination of two antihypertensive drugs in arterial hypertension

Conditions

  • Arterial Hypertension

Interventions

DRUG

Tripliam (perindopril, indapamide, amlodipine)

Fixed combination of perindopril 5 mg, indapamide 1,25 and amlodipine 5 mg

DRUG

Reaptan (perindopril, amlodipine)

Fixed combination of perindopril 10 mg and amlodipine 5 mg

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Carlo Gaudio, MD · Sapienza University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-03-31
Completion
2020-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710552 on ClinicalTrials.gov